<DOC>
	<DOCNO>NCT01809717</DOCNO>
	<brief_summary>This study establich feasibility weight lift exercise among patient multiple myeloma , determine weight lift exercise increase lean body mass among patient multiple myeloma obtain preliminary data toxicity pharmacokinetics high-dose melphalan .</brief_summary>
	<brief_title>Multiple Myeloma Exercise</brief_title>
	<detailed_description>This prospective , single-institution , pilot study 3 month weight lift program design increase musle hypertrophy prior start stem cell collection receive high-dose melphalan , patient multiple myeloma . We use exercise intervention patient receive initial induction chemotherapy 3-6 month period receiv high-dose melphalan . The primary study endpoint determine feasibility recruit retain multiple myeloma patient exercise intervention trial . The secondary study endpoint determine whether weight lift program increase lean body mass intend .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Histologically confirm multiple myeloma 1 year since start treatment myeloma Patient treat physician agreement proceed autologous transplant , plan time betwwen study enrollment transplant 10 week Age 18 year . Able walk 6 minute unaided . Body mass index 50 kg/m2 Serum creatinine 2.5 mg/dL Ability understand inform consent document willingness consent . Written informed consent must obtain patient study entry . Recent ( past 6 month ) participation progressive weight lift exercise already exercise regulary ( 3 time week moderate intensity aerobic exercise ) . Plan move area study intervention . A psychological , social , logistical barrier principal investigator feel would preclude completion study protocol . Plan use antimyeloma treatment melphalan ( use total body irradiation NOT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>